Literature DB >> 18608994

Systems biology of vascular endothelial growth factors.

Feilim Mac Gabhann1, Aleksander S Popel.   

Abstract

Several cytokine families have roles in the development, maintenance, and remodeling of the microcirculation. Of these, the vascular endothelial growth factor (VEGF) family is one of the best studied and one of the most complex. Five VEGF ligand genes and five cell-surface receptor genes are known in the human, and each of these may be transcribed as multiple splice isoforms to generate an extensive family of proteins, many of which are subject to further proteolytic processing. Using the VEGF family as an example, we describe the current knowledge of growth-factor expression, processing, and transport in vivo. Experimental studies and computational simulations are being used to measure and predict the activity of these molecules, and we describe avenues of research that seek to fill the remaining gaps in our understanding of VEGF family behavior.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608994      PMCID: PMC2722038          DOI: 10.1080/10739680802095964

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  176 in total

1.  Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.

Authors:  P Carmeliet; Y S Ng; D Nuyens; G Theilmeier; K Brusselmans; I Cornelissen; E Ehler; V V Kakkar; I Stalmans; V Mattot; J C Perriard; M Dewerchin; W Flameng; A Nagy; F Lupu; L Moons; D Collen; P A D'Amore; D T Shima
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions.

Authors:  S Yamagishi; H Yonekura; Y Yamamoto; H Fujimori; S Sakurai; N Tanaka; H Yamamoto
Journal:  Lab Invest       Date:  1999-04       Impact factor: 5.662

3.  Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165.

Authors:  S Gengrinovitch; B Berman; G David; L Witte; G Neufeld; D Ron
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

4.  Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.

Authors:  P Salven; A Orpana; H Joensuu
Journal:  Clin Cancer Res       Date:  1999-03       Impact factor: 12.531

5.  Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.

Authors:  M Dougher; B I Terman
Journal:  Oncogene       Date:  1999-02-25       Impact factor: 9.867

6.  Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase. A real time kinetic study.

Authors:  S A Cunningham; T M Tran; M P Arrate; T A Brock
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

7.  VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells.

Authors:  Y Feng; V J Venema; R C Venema; N Tsai; R B Caldwell
Journal:  Biochem Biophys Res Commun       Date:  1999-03-05       Impact factor: 3.575

8.  Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

Authors:  R Soldi; S Mitola; M Strasly; P Defilippi; G Tarone; F Bussolino
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

9.  Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding.

Authors:  C J Dowd; C L Cooney; M A Nugent
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

10.  Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.

Authors:  H Wang; J A Keiser
Journal:  Circ Res       Date:  1998-10-19       Impact factor: 17.367

View more
  72 in total

Review 1.  How blood vessel networks are made and measured.

Authors:  John C Chappell; David M Wiley; Victoria L Bautch
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

Review 2.  Theoretical models for coronary vascular biomechanics: progress & challenges.

Authors:  Sarah L Waters; Jordi Alastruey; Daniel A Beard; Peter H M Bovendeerd; Peter F Davies; Girija Jayaraman; Oliver E Jensen; Jack Lee; Kim H Parker; Aleksander S Popel; Timothy W Secomb; Maria Siebes; Spencer J Sherwin; Rebecca J Shipley; Nicolas P Smith; Frans N van de Vosse
Journal:  Prog Biophys Mol Biol       Date:  2010-10-30       Impact factor: 3.667

3.  Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking.

Authors:  Wan Hua Tan; Aleksander S Popel; Feilim Mac Gabhann
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

4.  Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.

Authors:  P I Imoukhuede; Aleksander S Popel
Journal:  Exp Cell Res       Date:  2010-12-23       Impact factor: 3.905

Review 5.  Systems biology of the microvasculature.

Authors:  Lindsay E Clegg; Feilim Mac Gabhann
Journal:  Integr Biol (Camb)       Date:  2015-04-02       Impact factor: 2.192

Review 6.  Systems biology of pro-angiogenic therapies targeting the VEGF system.

Authors:  Feilim Mac Gabhann; Amina A Qutub; Brian H Annex; Aleksander S Popel
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

7.  Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Aleksander S Popel
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 8.  The microcirculation: physiology at the mesoscale.

Authors:  Timothy W Secomb; Axel R Pries
Journal:  J Physiol       Date:  2011-01-17       Impact factor: 5.182

Review 9.  Harnessing systems biology approaches to engineer functional microvascular networks.

Authors:  Lauren S Sefcik; Jennifer L Wilson; Jason A Papin; Edward A Botchwey
Journal:  Tissue Eng Part B Rev       Date:  2010-06       Impact factor: 6.389

10.  MMP14 Cleavage of VEGFR1 in the Cornea Leads to a VEGF-Trap Antiangiogenic Effect.

Authors:  Kyu-Yeon Han; Jennifer Dugas-Ford; Hyun Lee; Jin-Hong Chang; Dimitri T Azar
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.